This content is in French.
Neurodegeneration: the shadow of a deficiency?
18 juin 2025
#Alzheimer #MS #Parkinson #ALS #VitaminD
Neurodegenerative diseases such as multiple sclerosis (MS), Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS) represent a major global public health challenge. Their prevalence is steadily increasing, notably due to demographic aging. These conditions are characterized by a progressive, irreversible, and often multifocal loss of neurological functions, leading to cognitive, motor, sensory, or respiratory deficits depending on the disease.
Neurodegenerative diseases such as multiple sclerosis (MS), Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS) represent a major global public health challenge. Their prevalence is steadily increasing, notably due to demographic aging. These conditions are characterized by a progressive, irreversible, and often multifocal loss of neurological functions, leading to cognitive, motor, sensory, or respiratory deficits depending on the disease.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Savran, Z., et al. (2025). Vitamin D and Neurodegenerative Diseases Such as MS, Parkinson's Disease (PD), Alzheimer's Disease (AD), and Amyotrophic Lateral Sclerosis (ALS): A Review of Current Literature. Current nutrition reports, 14(1), 77
View the source
